SWOG clinical trial number
SWOG-8855

Prognostic Value of Cytometry Measurements of Cellular DNA Parameters in Head and Neck Cancer Patients, Ancillary

Closed
Phase
Published
Abbreviated Title
Ancillary
Activated
09/15/1990
Closed
09/01/2002
Participants
NCORP, Members, Medical Oncologists, Radiation Oncologists, Surgeons, Pathologists, ECOG, RTOG

Research committees

Head and Neck Cancer

Eligibility Criteria Expand/Collapse

Registration to any Southwest Oncology Group protocol listed above; adequate tissue for flow cytometry is required.

Flow Cytometry for SWOG-8590, SWOG-8892, SWOG-8810, SWOG-8852, SWOG-9059, SWOG-9201, SWOG-8803, and SWOG-9515

Publication Information Expand/Collapse

1997

DNA content parameters in advanced, resectable squamous cell carcinomas of the head and neck (SCCHN); analysis of INT 0034, a RTOG (8503)-administered head and neck cancer intergroup trial.

JF Ensley;G Laramore;T Pajak;M Alonso;H Pietraskiewicz;K Fu;A Forastiere;G Adams;D Schuller;M Al-Sarraf Proc of the American Society of Clinical Oncology 16:390a(#1393)

Translational intermediates: Clinical and laboratory perspectives in head and neck cancer.

JF Ensley Presented at the 5th US-Japan Clincial Trials Summit-Kyoto Japan 9/19-20 :

1994

Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck

JF Ensley;Z Maciorowski Seminars in Oncology 21(3):330-339

1993

The selection of patients with advanced squamous cell carcinoma of the head and neck for clinical trials based on tumor DNA content parameters

J Ensley;H Pietraszkiewicz;A Pear;W Sakr;M Alonso;Z Maciorowski Adjuvant Therapy of Cancer VII:99-107

1990

Clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck.

JF Ensley;Z Maciorowski;H Pietraszkiewicz;F deBraud;W Sakr;J Kish;M Al-Sarraf;E Tapazoglou Adjuvant Therapy of Cancer IV:101-108

Methodology and clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck.

JF Ensley;Z Maciorowski;H Pietraszkiewicz;F deBraud;W Sakr Carcinoma of the Head and Neck Evaluation of Management :225-242

Prospective correlation of cytotoxic response and DNA content parameters in advanced squamous cell cancer of the head and neck (SCCHN).

J Ensley;Z Maciorowski;H Pietraszkiewicz;J Kish;E Tapazoglou;J Jacobs;R Mathog;W Sakr;M Al-Sarraf;B Metch;D Schuller;C Coltman, Jr ASCO 9:173(#671)

Prospective correlation of cytotoxic response and DNA content parameters in advanced squamous cell cancer of the head and neck (SCCHN).

J Ensley;Z Maciorowski;H Pietraszkiewicz;J Kish;E Tapazoglou;J Jacobs;R Mathog;W Sakr;M Al-Sarraf;B Metch;D Schuller;C Coltman, Jr ASCO 9:173(#671)